Calvin Cao

Mr. Cao’s is the founder of CZ BioMed Corp. As an inventor, innovator and Bio-Entrepreneur, his strategy and commitment to make CZ Biomed the dominant global company on the discovery and development of a new class of high-tech biological products for the treatment of a wide variety of human cancers.

In 2008, As a chairman and co-founder of Stem Cell Therapy International Corp. He engineered the recent merger of Stem Cell Therapy International and Histostem of South Korea. Histostem, one of the largest fully accredited cord blood banks in the world, with more than 80,000 cord blood units for use in research and treatments. The successful merger has formed one of the first fully merged Pacific Rim stem cell companies and cord blood repositories with a U.S. entity Amstem Corp.